Target intelligence / Profile preview

LMO7 antisense RNA 1 (LMO7-AS1)

Target: LMO7-AS1
Molecular classification: Long non-coding RNA (lncRNA), Other

Overview

LMO7 antisense RNA 1 (LMO7-AS1) is a long non-coding RNA (lncRNA) located on chromosome 13. It is transcribed from the DNA strand opposite to the protein-coding LMO7 gene and may regulate the expression of LMO7 through mechanisms such as transcriptional interference or modulation of chromatin structure. Its precise biological role remains uncertain, but preliminary research suggests it may play a part in cellular proliferation and differentiation. LMO7-AS1 is also known as UCHL3-AS1 due to its genomic proximity and transcript overlap with the UCHL3 gene in some contexts; these aliases are interchangeable in recent bioinformatic and gene databases. There are currently no drugs targeting this molecule, and no clinical safety concerns have been recorded in the literature.

Other names: LMO7-AS1UCHL3-AS1UCHL3 antisense RNA 1

Mechanism of action

None documented for drug targeting (as lncRNAs are not typical drug targets)

Biological functions

Regulation of gene expression (specifically, of the protein-coding gene LMO7)Possible involvement in cell proliferation and differentiationOther (exact functions remain undetermined)

Disease associations

Evidence exists for its genetic region in association with diabetic retinopathyPotential involvement in red blood cell traitsOther (the biological and disease relevance remains under investigation)

Safety considerations

None documented (not a therapeutic target)

Interacting drugs

None have been reported in the literature or referenced databases as of the most recent update

Biomarkers

Genetic variants in the LMO7-AS1/LMO7 locus (e.g., rs3818355, rs2224797) may act as biomarkers for diabetic retinopathy and red blood cell traits, but this pertains to the locus, not this RNA individually

Beyond the preview

Go deeper on LMO7 antisense RNA 1 (LMO7-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LMO7 antisense RNA 1 (LMO7-AS1).

Explore the full profile